U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. OTAT Town Hall: Cell Therapy Chemistry, Manufacturing, and Controls - 12/07/2022
  1. News & Events

Town Hall | Virtual

Event Title
OTAT Town Hall: Cell Therapy Chemistry, Manufacturing, and Controls
December 7, 2022

Date:
December 7, 2022
Time:
12:00 p.m. - 1:30 p.m. ET

The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Tissues and Advanced Therapies (OTAT) hosted a virtual town hall to answer stakeholder questions related to cell therapy chemistry, manufacturing, and controls (CMC), including tissue-engineered medical products regulated by OTAT. This event was part of a series to answer questions from stakeholders about a variety of topics on which OTAT has regulatory oversight.

View the recording for the OTAT Town Hall on Cell Therapy Chemistry, Manufacturing, and Controls and Tissue-engineered Medical Products.

Focus For This Town Hall: What Are Chemistry, Manufacturing, and Controls for Cell Therapy and Tissue-engineered Products?

The FDA requires sponsors to provide CMC information as part of an investigational new drug application. The CMC information should describe product manufacturing and testing to assure safety, identity, quality, purity, and strength (including potency) of the investigational product. Please see this FDA guidance document for more information.

Note: On September 29, 2022, OTAT held a town hall about gene therapy CMC. View the town hall announcement page for the meeting recording and other meeting materials.

Submit a Question

This event has concluded. To see a list of future OTAT events, please visit the events calendar.

Please note, the FDA is not able to comment on or answer questions regarding specific investigational products or drug applications during the town hall. Further, questions considered inappropriate or out of scope for the event will not be addressed.

About the OTAT Town Hall Series

OTAT launched its virtual town hall series to engage with product development stakeholders and discuss topics related to OTAT-regulated products. The town halls have a question-and-answer format with the goal of providing regulatory information to stakeholders to advance drug development. Learn more about OTAT and view our available resources.

Stay Connected

Sign up for the CBER listserv or follow us on social media to stay up to date on all FDA CBER news and events.

Back to Top